VAC077: Safety and Immunogenicity of the Pfs25-IMX313/Matrix-M Vaccine
NCT04130282
·
clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
1
Enrollment
OTHER
Sponsor class
Stopped
Delays caused by Covid-19
Conditions
Malaria,Falciparum
Interventions
BIOLOGICAL:
Pfs25-IMX313/Matrix-M1
Sponsor
University of Oxford